A new list of 27 new dividend increases, including King Kimberly-Clark and three other champions.
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
Elevance Health (ELV) closed at $512.17 in the latest trading session, marking a +0.55% move from the prior day.

3 Dividend Contenders To Grow Your Income

03:40pm, Wednesday, 21'st Feb 2024
Today, we are looking at some dividend contenders and then applying further criteria based on growth, payout ratio and valuation to find 25 names worth exploring further. We then give three companies
Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and Apollo Medical Holdings, Inc. (AMEH). But which of these two companies is the b
Here is how Elevance Health (ELV) and HCA Healthcare (HCA) have performed compared to their sector so far this year.

10 Dividend Growth Stocks: February 2024

09:00am, Monday, 19'th Feb 2024
In this series, I rank a selection of dividend growth stocks in Dividend Radar and present the ten top-ranked stocks for consideration. To rank stocks, I do a quality assessment and sort stocks by qua
The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most.
Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those l
Here is how Elevance Health (ELV) and McKesson (MCK) have performed compared to their sector so far this year.
Elevance Health reported Q4 earnings that beat expectations for both EPS and revenue. The company exceeded its 2023 guidance but disappointed with its 2024 guidance, predicting flat to low single-digi
Elevance Health rewarded shareholders with a 10.1% hike in its quarterly dividend per share. The managed care company's operating revenue and adjusted diluted EPS climbed in the fourth quarter. Elevan
Sector components forecast to show the biggest earnings year-over-year earnings improvement include Humana Inc. NYSE: HUM, Elevance Health Inc. NYSE: ELV, Incyte Corp. NASDAQ: INCY, Insulet Corp.
Elevance Health (ELV) expects 2024 premium revenues to remain in line with the 2023 level.
While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE